The Effect of AMP Human Sodium Bicarbonate Lotion on Dehydrated Heat Stress
NCT05092854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2022-10-24
Summary
The primary purpose of the proposed study is to evaluate the effects of a topical sodium bicarbonate lotion (PR Lotion, AMP Human, Park City, UT) on measures of hydration status and fluid balance in humans when exposed to the heat while resting and during light/moderate aerobic exercise. A secondary purpose is to examine these same effects with two differing dosage patterns of the lotion. A tertiary purpose is to investigate the effect of an amino acid rehydration beverage in comparison to a placebo on measurements of hydration, subjective assessments of stress, and vestibular as well as musculoskeletal measures of fatigue for up to 24-hours after the completion of both passive and exertional heat stress within a dehydrated state.
Conditions
- Fluid Retention
- Sodium Retention
- Heat Stress
- Dehydration (Physiology)
- Renal Injury
- Electrolyte and Fluid Balance Conditions
Interventions
- OTHER
-
PR Lotion - AMP Human Performance
Sodium Bicarbonate Topical Solution. For use of the PR Lotion solution, consumers are instructed to apply the lotion to areas of the body that have been identified as most likely to use during their activity (i.e. calves and thighs for runners, shoulders and forearms for swimmers, etc.). Moreover, the product can be applied up to 2 hours prior to beginning a workout or event with one use supporting a 4-6 hour workout. AMP Human has also verified the safety of their product as being well tolerated in consumers \>2 years of age unless there is a known allergy to an ingredient on the label. Moreover, to the company's knowledge no side effects have been reported per the SAFETY Section at https://amphuman.com/pages/faq. Other Names: NDC Code: 72358-101-01 NDC Code: 72358-101-02 NDC Code: 72358-101-03
- OTHER
-
Placebo Lotion
Placebo Topical Solution. Lotion will be created by the AMP Human Performance company and will include all ingredients similar to the PR Lotion product except for the exclusion of sodium bicarbonate.
- OTHER
-
AminoVital - Rapid Recovery
AminoVITAL Rapid Recovery is a commercially available supplement that is not currently regulated by the FDA but does complete both internal quality control and third-party testing for all of their products. AminoVITAL Rapid Recovery has been certified by the Banned Substance Control Group (BSCG; https://www.bscg.org/certified-drug- free-supplements/?AminoVITAL) and has been certified to be free of 496+ drugs including WADA Prohibited Substances as well as prescription, over the counter, and illicit drugs not banned in sport. AminoVITAL Rapid Recovery is safe to consume multiple times within a single day and has been found most effective when taken within 30 minutes of cessation of exercise. No known side effects are associated with the ingestion of aminoVITAL Rapid Recovery; however, side effects of amino acid toxicity include gastrointestinal distress, nausea and headache.
- OTHER
-
Placebo Supplement
Supplement will be created by the aminoVITAL company and will include all ingredients similar to the commercially available Rapid Recovery product except for the exclusion of the amino acid blend.
Sponsors & Collaborators
-
AMP Human; Park City, UT
collaborator UNKNOWN -
United States Department of Defense
collaborator FED -
University of Connecticut
lead OTHER
Principal Investigators
-
Douglas J Casa, PhD · Korey Stringer Institute - UConn
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-03
- Primary Completion
- 2022-08-01
- Completion
- 2022-08-01
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males
NCT05428774 ·Status: COMPLETED ·Phase: NA
-
Human Hydration Status Monitoring
NCT01124903 ·Status: COMPLETED ·Phase: NA
-
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Rehydration Therapy in Burn Patients
NCT02124265 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428228 ·Status: RECRUITING ·Phase: NA
-
Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients
NCT04953013 ·Status: COMPLETED
-
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
NCT04319731 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
NCT05060523 ·Status: UNKNOWN ·Phase: NA
-
Exploring Water-free Sodium Storage
NCT06872645 ·Status: RECRUITING ·Phase: NA
-
Tolvaptan for In-hospital Hyponatremia
NCT01386372 ·Status: TERMINATED ·Phase: PHASE2
-
Lactated Ringer's and PlasmaLyte in Critically Ill Adults
NCT03813563 ·Status: UNKNOWN
-
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01227512 ·Status: TERMINATED ·Phase: PHASE3
-
Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers
NCT01458873 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Biomarkers for Noninvasive Assessment of Human Hydration
NCT01507129 ·Status: COMPLETED
-
Beverage Hydration Index: Assessment of Four Rehydration Solutions
NCT06272435 ·Status: COMPLETED ·Phase: NA
-
Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury
NCT01627613 ·Status: COMPLETED ·Phase: PHASE2
-
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
NCT03330704 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
NCT03846258 ·Status: WITHDRAWN ·Phase: PHASE4
-
Maintenance Intravenous Fluids in Children
NCT00621348 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655 ·Status: UNKNOWN ·Phase: NA
-
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
NCT00656370 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
NCT01168947 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis
NCT04621981 ·Status: UNKNOWN ·Phase: NA
-
Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury
NCT04522635 ·Status: COMPLETED ·Phase: PHASE4
-
Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
NCT02689635 ·Status: TERMINATED ·Phase: NA